Previous issue | Volume 94 | ESPE2021

59th Annual ESPE (ESPE 2021 Online)

Online,
22 Sep 2021 - 26 Sep 2021

Card image cap
The 59th ESPE Annual Meeting will now be held online in September 2021.

ePoster Category 1

Adrenal A

Optimizing the timing of highest hydrocortisone dose in children and adolescents with 21-hydroxylase deficiency
1Amalia Children’s Hospital, Radboud University Medical Center, Department of Pediatrics, Nijmegen, The The Netherlands; 2Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands; 3Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands; 4Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; 5Beatrix Children’s Hospital, Department of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands; 6Leiden University Medical Centre, Leiden, The Netherlands; 7Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands; 8Wilhelmina Children’s Hospital, Utrecht University Medical Center, Utrecht, The Netherlands; 9Department of Endocrinology, Juliana’s Children’s Hospital, The Hague, The Netherlands; 10Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands; 11Zuyderland Medical Center, Heerlen, The Netherlands; 12Maastricht University Medical Center, Maastricht, The Netherlands; 13Catharina Hospital, Eindhoven, The Netherlands
hrp0094p1-1
Adrenocortical hormone profiles do not predict the molecular etiology in non-CAH primary adrenal insufficiency
1Department of Pediatric Endocrinology and Diabetes, Marmara University, School of Medicine, Istanbul, Turkey; 2Department of Pediatric Genetics, Umraniye Research and Training Hospital, University of Health Sciences, Istanbul, Turkey; 3Department of Pediatric Endocrinology, Haseki Training and Research Hospital, Istanbul, Turkey; 4Department of Pediatric Endocrinology and Diabetes, Kanuni Sultan Suleyman Research and Training Hospital, University of Health Sciences, Istanbul, Turkey; 5Department of Pediatric Endocrinology and Diabetes, Behcet Uz Education and Research Hospital, Izmir, Turkey; 6Department of Pediatrics, Duzce University, School of Medicine, Bolu, Turkey; 7Department of Pediatric Endocrinology and Diabetes, Ataturk University, School of Medicine, Erzurum, Turkey; 8Department of Pediatric Endocrinology and Diabetes, Istanbul Medeniyet University Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey; 9Department of Pediatric Endocrinology, Kartal Training and Research Hospital, Istanbul, Turkey; 10Department of Pediatric Endocrinology, Aydin Adnan Menderes University, School of Medicine, Aydin, Turkey; 11Department of Pediatric Endocrinology and Diabetes, Kosuyolu İstanbul Medipol Hospital, Istanbul, Turkey; 12Department of Pediatric Endocrinology and Diabetes, Selcuk University, School of Medicine, Konya, Turkey; 13Department of Pediatric Endocrinology and Diabetes, Dokuz Eylul University, School of Medicine, Izmir, Turkey; 14Department of Pediatric Endocrinology and Diabetes, Onsekiz Mart University, School of Medicine, Canakkale, Turkey; 15Department of Pediatric Endocrinology and Diabetes, Umraniye Research and Training Hospital, University of Health Sciences, Istanbul, Turkey; 16Department of Pediatric Endocrinology and Diabetes, Derince Research and Training Hospital, Kocaeli, Turkey; 17Department of Pediatrics, Gungoren Hospital, Istanbul, Turkey
hrp0094p1-2
Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real-World Evidence from the I-CAH Registry
1Neurocrine Biosciences, Inc., San Diego, USA; 2IQVIA Inc., Plymouth Meeting, USA; 3Developmental Endocrinology Research Group, Royal Hospital for Children, University of Glasgow, Glasgow, United Kingdom; 4Office for Rare Conditions, University of Glasgow, Glasgow, United Kingdom; 5Department of Oncology and Metabolism, The University of Sheffield Medical School, Sheffield, United Kingdom; 6Department Hospital of Woman and Child, Pediatric Unit, IRCSS AOU S.Orsola-Malpighi University Hospital, Bologna, Italy; 7Radboud University Nijmegen, Amalia Childrens Hospital, Department of Pediatric Endocrinology, Nijmegen, Netherlands; 8Department of Paediatrics, Technical University München, Munich, Germany; 9On behalf of the I-CAH Consortium, Glasgow, United Kingdom
hrp0094p1-3
Depression among insured children and young adults in the United States with congenital adrenal hyperplasia
1University of Minnesota Medical School, Department of Pediatrics, Minneapolis, USA; 2National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, USA; 3University of Minnesota Medical School, Department of Psychiatry and Behavioral Science, Minneapolis, USA; 4University of Minnesota Masonic Children’s Hospital, Divisions of Pediatric Endocrinology and Genetics & Metabolism, Minneapolis, USA
hrp0094p1-4
International practice of therapy monitoring in congenital adrenal hyperplasia - Real World data from the I-CAH registry
1Department of Oncology and Metabolism,The University Of Sheffield, Sheffield, United Kingdom; 2Sheffield Children’s Hospital NHS Foundation Trust, Sheffield, United Kingdom; 3Institute of Work Psychology, Sheffield University Management School, Sheffield, United Kingdom; 4Developmental Endocrinology Research Group, University of Glasgow, Glasgow, United Kingdom; 5Department of Pediatric Endocrinology, Sophia Children’s Hospital, Erasmus Medical Centre, Rotterdam, Netherlands; 6Department of Internal Medicine, University of Sao Paulo, Sao Paulo, Brazil; 7Department of Medical and Surgical Sciences, Pediatric Unit, Endo-ERN Center for Rare Endocrine Diseases, S.Orsola-Malpighi University Hospital, Bologna, Italy; 8Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark; 9Department of Pediatrics, Technical University Munich, Munich, Germany; 10Department of Pediatrics, Klinikum Wels-Grieskirchen, Wels, Austria; 11Department of Pediatric Endocrinology, Radboud University Medical Centre, Nijmegen, Netherlands; 12Pediatric Surgery Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; 13Institute for Diabetes and Endocrinology, Schneider’s Children Medical Center of Israel, Petah-Tikvah, Israel; 14Pediatrics Department, Ain Shams University, Cairo, Egypt; 15Pediatric Endocrinology, Baskent University İstanbul Hospital, Istanbul, Turkey; 16Department of Paediatrics, Leiden University Medical Centre, Leiden, Netherlands; 17Department of Paediatrics, Medical University of Varna, Varna, Bulgaria; 18Pediatric Endocrinology Wilhelmina Children’s Hospital, University Medical Centre Utrecht, Utrecht, Netherlands; 19Servicio de Endocrinología pediátrica. Hospital Universitario Vall d’Hebron. CIBER de Enfermedades Raras (CIBERER) ISCIII, Barcelona, Spain; 20Department of Endocrinology, University of Medicine and Pharmacy Craiova, Craiova, Romania; 21Department of Endocrinology, Institute for Mother and Child Healthcare of Serbia “Dr Vukan Čupić”, Belgrade, Serbia; 22Institute for Experimental Pediatric Endocrinology and Center for Chronically Sick Children, Charite - Universitätsmedizin, Berlin, Germany; 23Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden; 24Department of Paediatric Endocrinology, Astrid Lindgren Children Hospital, Karolinska University Hospital, Stockholm, Sweden; 25Paediatric Endocrinology Unit, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey; 26Pediatric Department, Kantonsspital Winterthur, Winterthur, Switzerland; 27Department of Paediatric Endocrinology, Regina Margherita Children’s Hospital, University of Torino, Torino, Italy; 28Department of Pediatrics, University of Cambridge, Cambridge, United Kingdom; 29Biomedical Campus, Cambridge, United Kingdom; 30Centro de Investigaciones Endocrinológicas (CEDIE-CONICET), Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina; 31Pediatric Endocrinology and Diabetes, Marmara University, Istanbul, Turkey
hrp0094p1-6
Brain activity during working memory in congenital adrenal hyperplasia
1Karolinska Institute, Stockholm, Sweden; 2Danish Technical University, Lyngby, Denmark
hrp0094p1-7
Long-term Cardiometabolic Morbidity In Young Adults With Classic 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
1Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital For Sick Children, Yorkhill, Glasgow, United Kingdom; 2Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, United Kingdom; 3Oxford Centre for Diabetes, Endocrinology & Metabolism, NIHR Oxford Biomedical Research Centre, Churchill Hospital, University of Oxford, Oxford, United Kingdom; 4Department of Paediatrics, Technical University München, Munich, Germany; 5Department of Paediatrics, Klinikum Wels-Grieskirchen, Wels, Austria; 6Pediatric Unit, Department Hospital of Woman And Child, IRCSS S.Orsola-Malpighi University Hospital, Bologna, Italy; 7Pediatric Surgery Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; 8Department of Pediatrics, School of Medicine, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil; 9Department of Endocrinology - Center for Sexology and Gender, Ghent University Hospital, Ghent, Belgium; 10Department of Internal Medicine and Paediatrics, Ghent University and Pediatric Endocrinology Service, Ghent University Hospital, Ghent, Belgium; 11Endocrinology, Yerevan State Medical University Endocrinology Clinic, Yerevan, Armenia; 12Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular/LIM42, Disciplina de Endocrinologia, Hospital Das Clinicas, Faculdade De Medicina, Universidade de São Paulo, São Paulo, Brazil; 13UMHAT Sveta Marina, Medical University of Varna, Varna, Bulgaria; 14Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden; 15Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden; 16Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padua, Padua, Italy; 17Department of Pediatrics, Endocrine Unit, IRCCS San Raffaele Scientific Institute, Endo-ERN Center for Rare Endocrine Conditions, Milan, Italy; 18Department of Endocrinology, Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic", Belgrade, Serbia; 19Department of Clinical and Biological Sciences and Division of Endocrinology, Diabetes and Metabolism-Department of Medical Sciences, University of Turin, Turin, Italy; 20Department of Clinical Genetics, National Research Center, Cairo, Egypt; 21Pediatric Endocrinology, Baskent University İstanbul Hospital, Istanbul, Turkey; 22Department of Pediatric Endocrinology, Istanbul University, Istanbul Medical School, Istanbul, Turkey; 23Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 24The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Schneider Children’s Medical Center of Israel, Petah-Tikva, Israel; 25Faculty of Medical Laboratory Sciences, Al-Neelain University, Khartoum, Sudan; 26Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom; 27Department of Endocrinology, St Albans City Hospital, West Hertfordshire Hospitals Trust, St Albans, United Kingdom; 28Department of Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, United Kingdom; 29Department of Endocrinology, Guy’s & St. Thomas’ NHS Foundation Trust, London, United Kingdom; 30The Christie NHS Foundation Trust, Manchester, United Kingdom; 31Queen Elizabeth University Hospital, Glasgow, United Kingdom; 32Department of Endocrinology, Salford Royal Foundation Trust, Salford, United Kingdom; 33Department of Diabetes and Endocrinology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; 34Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom; 35Ninewells Hospital, Dundee, United Kingdom; 36Medizinische Klinik IV, Klinikum der Universität München, München, Germany; 37Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, Netherlands; 38Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, USA
hrp0094p1-8
Backdoor Pathway hormones and 11-oxygenated Androgens are elevated in Patients with 21-hydroxylase deficiency
1University Hospital Schleswig-Holstein, Campus Kiel, Children’s Hospital, Department of Paediatrics, Division of Pediatric Endocrinology and Diabetes, Kiel, Germany; 2University of Witten/Herdecke, Vestische Hospital for Children and Adolescents, Datteln, Germany
hrp0094p1-9
Glucose regulation in children with primary adrenal insufficiency: preliminary data.

1Alder Hey Children’s Hospital, Liverpool, United Kingdom; 2University of Liverpool, Liverpool, United Kingdom; 3Liverpool Centre for Cardiovascular Science, Liverpool, United Kingdom; 4Liverpool Centre for Cardiovascular Science, Liverpool, United Kingdom

hrp0094p1-10